SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
Revenues down again, owing to intense competitive pricing pressures Pricing pressure continued to negati...
Typically, Q4 is a rebound quarter for Total Joints, but SmartTRAK reports that the Q418 US market exper...
01With the upcoming orthopedic conference season upon us, we thought it would be interesting to take a l...
.png)
SmartTRAK highlights trends shaping the Extremities Market It’s no surprise orthopedic companies continu...
Doug Devens, SmartTRAK's Senior Analyst, Biosurgery wrote a fascinating article titled "Growth Amid Deba...
OrthoXel is an orthopaedic trauma device company focused on evolving fracture fixation through evidence-...
Will you be attending AAOS this year? SmartTRAK will be exhibiting (booth #6847) and we’re hoping to sch...
Stem cell “secretome” is the latest advancement in regenerative medicine. Will it become the heart of ti...
Frederique Buntoum (aka Freddy) has joined BioMedGPS as Senior Analyst, Regenerative Medicine, overseein...
SmartTRAK is excited to be attending the AANS/CNS Joint Cerebrovascular Annual Meeting on Feb. 4-5, 2019...
Login